We recently published a list of the 10 High Growth Dividend Paying Stocks to Invest in. In this article, we are going to take ...

A Lilly statement said, "We will continue to take action to stop these illegal actors and urgently call on regulators and law ...

Amy Schumer shared she quit Wegovy due to side effects like nausea but was "having a really good experience" with Mounjaro, ...

Eli Lilly has launched Mounjaro in India, a once-weekly injection targeting both type 2 diabetes and obesity, priced at Rs 3,500 for a 2.5mg dose. This dual-action drug stimulates two key hormone ...

The drugmaker accuses Premier Weight Loss of risking patients' health by selling altered, unsterile versions of its ...

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs ...

Eli Lilly is suing Strive Pharmacy and Empower Pharmacy for compounding tirzepatide, the active ingredient in Zepbound and ...

We recently published a list of Billionaire Ken Fisher’s Top 13 Growth Stock Picks. In this article, we are going to take a ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's what you need to know. Amy Schumer has praised weight loss drug ...

Ozempic, the Danish pharma giant Novo Nordisk's anti-diabetic drug, has had everyone's attention over the past year. The injectable drug clinically known as semaglutide has made major promises ...

Global pharmaceutical major Eli Lilly, which recently launched its blockbuster anti-obesity drug Mounjaro (tirzepatide) in India, is planning to expand insulin production, collaborate on non ...

Eli Lilly's weight loss drug Mounjaro, launched last week in India at a significantly lower price than in the US, may still be out of reach for most Indian patients, doctors treating obesity told ...